Axcelis Technologies, Inc. (NASDAQ:ACLS) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. cut its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 21.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 178,923 shares of the semiconductor company's stock after selling 49,921 shares during the quarter. JPMorgan Chase & Co. owned 0.55% of Axcelis Technologies worth $18,760,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the company. Van ECK Associates Corp lifted its stake in Axcelis Technologies by 40.0% in the 3rd quarter. Van ECK Associates Corp now owns 23,751 shares of the semiconductor company's stock valued at $2,490,000 after buying an additional 6,786 shares in the last quarter. Royce & Associates LP boosted its stake in shares of Axcelis Technologies by 157.1% during the third quarter. Royce & Associates LP now owns 273,671 shares of the semiconductor company's stock valued at $28,694,000 after acquiring an additional 167,235 shares during the last quarter. Harbor Capital Advisors Inc. increased its position in Axcelis Technologies by 243.8% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 60,328 shares of the semiconductor company's stock worth $6,325,000 after purchasing an additional 42,779 shares in the last quarter. Annex Advisory Services LLC raised its stake in Axcelis Technologies by 72.0% in the 3rd quarter. Annex Advisory Services LLC now owns 12,226 shares of the semiconductor company's stock valued at $1,282,000 after purchasing an additional 5,118 shares during the last quarter. Finally, FMR LLC lifted its holdings in Axcelis Technologies by 51.4% in the 3rd quarter. FMR LLC now owns 263,332 shares of the semiconductor company's stock valued at $27,610,000 after purchasing an additional 89,453 shares in the last quarter. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Benchmark lowered shares of Axcelis Technologies from a "buy" rating to a "hold" rating in a research report on Friday, November 8th. Needham & Company LLC reiterated a "hold" rating on shares of Axcelis Technologies in a report on Friday, November 8th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $167.33.

Axcelis Technologies Trading Down 5.0 %

NASDAQ:ACLS traded down $3.66 during trading hours on Friday, reaching $69.44. 905,880 shares of the company were exchanged, compared to its average volume of 564,792. The firm has a market cap of $2.26 billion, a price-to-earnings ratio of 10.27, a PEG ratio of 2.36 and a beta of 1.53. The stock has a 50 day simple moving average of $75.15 and a 200 day simple moving average of $99.55. Axcelis Technologies, Inc. has a 52-week low of $67.27 and a 52-week high of $158.61. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.45 and a quick ratio of 3.29.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.